All lobbying filings

CGCN GROUP, LLC

Lobbying for PARTNER THERAPEUTICS, INC. · Biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $80,000.00 income · posted Apr 20, 2026

Official filing document

Lobbying activity 2

Defense

Issues related to medical countermeasures for Acute Radiation Syndrome (ARS).

Health Issues

Issues pertaining to the development of public health emergency medical countermeasures. Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.